• Gamco Investors appointed Eileen Cheigh Nakamura to board of directors.
• Nakamura is a healthcare investment executive with more than 30 years of experience at Pfizer, spanning finance, strategy, and portfolio management.
• At Pfizer, she led enterprise business assessment and portfolio prioritization, covering capital allocation across USD 12 billion in annual R&D and more than USD 80 billion in executed M&A.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gamco Investors Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605060915PRIMZONEFULLFEED9714336) on May 06, 2026, and is solely responsible for the information contained therein.